WEP CLINICAL EXPANDS AVAILABILITY OF XENLETA® (LEFAMULIN) NAMED PATIENT PROGRAM IN PARTNERSHIP WITH NABRIVA THERAPEUTICS Morrisville, NC, USA & London, UK – March 25, 2021 – WEP Clinical (WEP) and Nabriva Therapeutics (Nabriva) are pleased [...]